MilliporeSigma

Physicochemical characterization of Remsima.

mAbs (2014-12-18)
Soon Kwan Jung, Kyoung Hoon Lee, Jae Won Jeon, Joon Won Lee, Byoung Oh Kwon, Yeon Jung Kim, Jin Soo Bae, Dong-Il Kim, Soo Young Lee, Shin Jae Chang
ABSTRACT

Remsima (infliximab) was recently approved as the world's first biosimilar monoclonal antibody (mAb) in both the European Union and Korea. To achieve this, extensive physicochemical characterization of Remsima in relation to Remicade was conducted in order to demonstrate the highly similar properties between the two molecules. A multitude of state-of-the-art analyses revealed that Remsima has identical primary as well as indistinguishable higher order structures compared with the original product. Monomer and aggregate contents of Remsima were also found to be comparable with those of Remicade. In terms of charge isoforms, although Remsima was observed to contain slightly less basic variants than the original antibody, the difference was shown to be largely due to the presence of C-terminal lysine. On the other hand, this lysine was found to be rapidly clipped inside serum in vitro and in vivo, suggesting it has no effect on the biological potency or safety of the drug. Analysis of the glycan contents of the antibodies showed comparable glycan types and distributions. Recent results of clinical studies have further confirmed that the two antibody products are highly similar to each other. Based on this research as well as previous clinical and non-clinical comparability studies, Remsima can be considered as a highly similar molecule to Remicade in terms of physicochemical properties, efficacy, and safety for its final approval as a biosimilar product to Remicade.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Trifluoroacetic acid, ReagentPlus®, 99%
Sigma-Aldrich
Glycine, ReagentPlus®, ≥99% (HPLC)
Sigma-Aldrich
Acetonitrile solution, contains 0.1 % (v/v) trifluoroacetic acid, suitable for HPLC
Sigma-Aldrich
Acetonitrile solution, contains 0.05 % (v/v) trifluoroacetic acid
Sigma-Aldrich
Acetonitrile solution, contains 0.1 % (v/v) formic acid, suitable for HPLC
Sigma-Aldrich
Glycine, 99%, FCC
Sigma-Aldrich
Formic acid, ≥95%, FCC, FG
Supelco
Trifluoroacetic acid, analytical standard
Supelco
3,3′,5,5′-Tetramethylbenzidine, standard for GC
Sigma-Aldrich
3,3′,5,5′-Tetramethylbenzidine, ≥98.0% (NT)
Sigma-Aldrich
Glycine, tested according to Ph. Eur.
Sigma-Aldrich
DenoBridge ELISA Kit from rabbit serum
Sigma-Aldrich
UsteBridge ELISA Kit from rabbit serum
Sigma-Aldrich
InnoBridge ELISA Kit
Sigma-Aldrich
RemiBridge ELISA Kit
Sigma-Aldrich
EpoBridge ELISA Kit
Sigma-Aldrich
EnbrBridge ELISA Kit
Sigma-Aldrich
ErbiBridge ELISA Kit
Sigma-Aldrich
FilBridge ELISA Kit
Sigma-Aldrich
CampBridge ELISA Kit
Sigma-Aldrich
Glycine, BioXtra, ≥99% (titration)
Sigma-Aldrich
Glycine, suitable for electrophoresis, ≥99%
Sigma-Aldrich
3,3′,5,5′-Tetramethylbenzidine, tablet, 1 mg substrate per tablet
Sigma-Aldrich
Iodoacetamide, ≥99% (NMR), crystalline
SAFC
Glycine
Sigma-Aldrich
Iodoacetamide, Single use vial of 56 mg
Sigma-Aldrich
DL-Dithiothreitol solution, BioUltra, for molecular biology, ~1 M in H2O
Sigma-Aldrich
Iodoacetamide, BioUltra
Sigma-Aldrich
3,3′,5,5′-Tetramethylbenzidine, ≥98% (TLC)
Sigma-Aldrich
Glycine, from non-animal source, meets EP, JP, USP testing specifications, suitable for cell culture, ≥98.5%